October 24, 2006 (Toronto, ON) - Substitution of generic warfarin for brand-name warfarin (Coumadin, Bristol-Myers Squibb) has no appreciable effect on rates of INR testing or hospitalization for ...

The anti-clotting drug warfarin, commonly known by the brand name Coumadin, is no longer recommended for the treatment of atrial fibrillation except for a select subset of patients, according to ...

Bristol-Myers Squibb Co. said Monday it is recalling eight production lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. The company said the ...

There's a new drug in town for those suffering from atrial fibrillation (AFib), the most common form of abnormal heart rhythm. During atrial fibrillation, the heart's two small upper chambers tremble ...

Arieta, left, and Loren Peters. The use of the drug Coumadin was blamed in Loren Peters' death. For the Washington Post When Loren Peters arrived in the emergency room in October 2013, bruises covered ...

First-of-its-Kind Study to Evaluate Gene Identification Ability to Predict Patient Response and Improve Safety When Dosing World’s Leading Anti-Blood Clotting Drug ATLANTA--(BUSINESS WIRE)-- Iverson ...

Warfarin, a drug that prevents blood from clotting, has long been used for those at high risk of clots, and thus at an increased risk of stroke and other ills. A recent study indicates that not only ...

The anti-clotting drug warfarin, commonly known by the brand name Coumadin, is no longer recommended for the treatment of atrial fibrillation except for a select subset of patients, according to ...